Vegetos
(An International Journal of Plant Research & Biotechnology)
Plant molecular pharming in Africa for sustainable health and economic development
*Article not assigned to an issue yet
Review Articles | Published: 11 December, 2025
First Page: 0
Last Page: 0
Views: 10
Keywords: Genetic engineering, Molecular pharming, Virus like particles, Monoclonal antibodies
Abstract
Plant genetic engineering goes back to over 40 years ago with the first genetically modified tobacco expressing the nopaline synthase gene. Since then, genetic engineering has emerged as an important technology as various sectors have included it in their strategic plans with potential impact on healthcare, agriculture and industry. One important aspect is the engineering of plants as bioreactors for production of vaccines, monoclonal antibodies, pesticides, orphan drugs, dyes and many other recombinant novel products. This process is referred to as plant molecular pharming. Plant molecular pharming has numerous benefits over conventional methods such as the use of animal cell lines and prokaryotic systems to produce recombinant products. These benefits include cost effectiveness, rapid and high mass production, easy scalability, accessibility and sustainability. Some African countries such as South Africa have adopted plant molecular pharming and have increased human and infrastructural capacity development, collaborations, and public sensitisation coupled with enabling policies and regulatory frameworks. However, in most of Africa, the sector faces numerous challenges including the lack of funding and expertise, low public acceptance, and poor to inadequate polices and regulatory frameworks. Despite the caveats surrounding the technology, it remains a significantly important tool for addressing global health challenges and fostering biotechnology innovations. Therefore, this review explores plant molecular pharming methods and associated products, advantages, strategies taken to improve the technology, regulatory and social- economic issues surrounding the technology in Africa.
References
Abiri R, Valdiani A, Maziah M, Shaharuddin NA, Sahebi M, Yusof ZNB, Talei D (2016) A critical review of the concept of Transgenic plants: insights into pharmaceutical biotechnology and molecular farming. Curr Issues Mol Biol 18(1):21–42
Belcher MS, Vuu KM, Zhou A, Mansoori N, Ramos A, Thompson A, Shih MG, P. M (2020) Design of orthogonal regulatory systems for modulating gene expression in plants. Nat Chem Biol 16(8):857–865
Belhaj K, Chaparro-Garcia A, Kamoun S, Nekrasov V (2013) Plant genome editing made easy: targeted mutagenesis in model and crop plants using the crispr/cas system. Plant Methods 9:1–10
Bevan M, Barnes WM, Chilton M-D (1983) Strcuture and transcription of the nopaline synthase gene region of T-DNA. Nucleic Acids Res 11(2):369–385
Brillault L, Jutras PV, Dashti N, Thuenemann EC, Morgan G, Lomonossoff GP, Sainsbury F (2017) Engineering Recombinant virus-like nanoparticles from plants for cellular delivery. ACS Nano 11(4):3476–3484
Buyel J, Twyman R, Fischer R (2015) Extraction and downstream processing of plant-derived Recombinant proteins. Biotechnol Adv 33(6):902–913
Carvalho C, Gaspar A, Knight A, Vicente L (2018) Ethical and scientific pitfalls concerning laboratory research with non-human primates, and possible solutions. Animals 9(1):12
Chen Q (2022) Development of plant-made monoclonal antibodies against viral infections. Curr Opin Virol 52:148–160
Cid R, Bolívar J (2021) Platforms for production of protein-based vaccines: from classical to next-generation strategies. Biomolecules 11(8):1072
Dhama K, Natesan S, Iqbal Yatoo M, Patel SK, Tiwari R, Saxena SK, Harapan H (2020) Plant-based vaccines and antibodies to combat COVID-19: current status and prospects. Hum Vaccines Immunotherapeutics 16(12):2913–2920
Diamos AG, Hunter JG, Pardhe MD, Rosenthal SH, Sun H, Foster BC, Mason HS (2020) High level production of monoclonal antibodies using an optimized plant expression system. Front Bioeng Biotechnol 7:472
Doudna JA, Charpentier E (2014) The new frontier of genome engineering with CRISPR-Cas9. Science 346(6213):1258096
Dubey KK, Luke GA, Knox C, Kumar P, Pletschke BI, Singh PK, Shukla P (2018) Vaccine and antibody production in plants: developments and computational tools. Brief Funct Genomics 17(5):295–307
Duwadi K, Chen L, Menassa R, Dhaubhadel S (2015) Identification, characterization and down-regulation of cysteine protease genes in tobacco for use in Recombinant protein production. PLoS ONE 10(7):e0130556 https://doi.org/10.1371/journal.pone.0130556
Eidenberger L, Kogelmann B, Steinkellner H (2023) Plant-based biopharmaceutical engineering. Nat Reviews Bioeng, 21;1(6):426–439. https://doi.org/10.1038/s44222-023-00044-6
Ghattas M, Dwivedi G, Lavertu M, Alameh M-G (2021) Vaccine technologies and platforms for infectious diseases: current progress, challenges, and opportunities. Vaccines 9(12):1490
Goven J, Morris CM (2012) Regulating biopharming: the Prism of farmer knowledge. Sci as Cult 21(4):497–527
Grimsley N, Hohn B, Hohn T, Walden R (1986) Agroinfection, an alternative route for viral infection of plants by using the Ti plasmid. Proc Natl Acad Sci 83(10):3282–3286
Harris JR (2008) Good manufacturing practices (GMP) and related FDA guidelines. Pharmaceutical Manufacturing Handbook: Regulations and Quality, 1-115
He J, Lai H, Brock C, Chen Q (2012) A novel system for rapid and cost-effective production of detection and diagnostic reagents of West Nile virus in plants. BioMed Research International, 2012
Hensel G, Floss DM, Arcalis E, Sack M, Melnik S, Altmann F, Conrad U (2015) Transgenic production of an anti HIV antibody in the barley endosperm. PLoS ONE 10(10):e0140476. https://doi.org/10.1371/journal.pone.0140476
Hiatt A, Caffferkey R, Bowdish K (1989) Production of antibodies in Transgenic plants. Nature 342(6245):76–78
Hoekema A, Hirsch PR, Hooykaas PJ, Schilperoort RA (1983) A binary plant vector strategy based on separation of vir-and T-region of the Agrobacterium tumefaciens Ti-plasmid. Nature 303(5913):179–180
Huebbers J, Buyel J (2021) On the verge of the market–plant factories for the automated and standardized production of biopharmaceuticals. Biotechnol Adv 46:107681
Hurtado J, Acharya D, Lai H, Sun H, Kallolimath S, Steinkellner H, Chen Q (2020) In vitro and in vivo efficacy of anti-chikungunya virus monoclonal antibodies produced in wild‐type and glycoengineered Nicotiana benthamiana plants. Plant Biotechnol J 18(1):266–273
Clive J, Krattiger AF (1996) Global review of the field testing and commercialization of Transgenic plants: 1986 to 1995. Isaaa Briefs, No. 1. ISAAA: Ithaca, NY. pp. 31
Jung J-W, Shin J-H, Lee W-K, Begum H, Min C-H, Jang M-H, Kim S-R (2021) Inactivation of the β (1, 2)-xylosyltransferase and the α (1, 3)-fucosyltransferase gene in rice (Oryza sativa) by multiplex CRISPR/Cas9 strategy. Plant Cell Rep 40:1025–1035
Jupe F, Rivkin AC, Michael TP, Zander M, Motley ST, Sandoval JP, Nery JR (2019) The complex architecture and epigenomic impact of plant T-DNA insertions. PLoS Genet 15(1):e1007819
Kolotilin I (2022) Plant-produced Recombinant cytokines IL-37b and IL-38 modulate inflammatory response from stimulated human PBMCs. Sci Rep 12(1):19450
Krichevsky A, Zaltsman A, King L, Citovsky V (2012) Expression of complete metabolic pathways in Transgenic plants. Biotechnol Genet Eng Rev 28(1):1–14
Li T, Sun JK, Lu ZH, Liu Q (2011) Transformation of HBsAg (hepatitis B surface antigen) gene into tomato mediated by Agrobacterium tumefaciens. Czech J Genet Plant Breed 47(2):69–77
Li Y, Sun M, Liu J, Yang Z, Zhang Z, Shen G (2006) High expression of foot-and-mouth disease virus structural protein VP1 in tobacco chloroplasts. Plant Cell Rep 25:329–333
Liu Y, Yan Q, Zeng Z, Fan C, Xiong W (2024) Advances and prospects of mRNA vaccines in cancer immunotherapy. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, 189068
Ma JK-C, Hiatt A, Hein M, Vine ND, Wang F, Stabila P, Lehner T (1995) Generation and assembly of secretory antibodies in plants. Science 268(5211):716–719
Ma JKC, Christou P, Chikwamba R, Haydon H, Paul M, Ferrer MP, Wigdorowitz A (2013) Realising the value of plant molecular pharming to benefit the poor in developing countries and emerging economies. Plant Biotechnol J 11(9):1029–1033
Magnusdottir A, Vidarsson H, Björnsson JM, Örvar BL (2013) Barley grains for the production of endotoxin-free growth factors. Trends Biotechnol 31(10):572–580
Maima AO, Munyendo WL (2018) Contemporary Advances and Precincts of Biopharming as Drugs’ Production Systems
Matsuo K, Atsumi G (2019) CRISPR/Cas9-mediated knockout of the RDR6 gene in Nicotiana benthamiana for efficient transient expression of Recombinant proteins. Planta 250:463–473
Mbewana S, Mortimer E, Pêra FF, Hitzeroth II, Rybicki EP (2015) Production of H5N1 influenza virus matrix protein 2 ectodomain protein bodies in tobacco plants and in insect cells as a candidate universal influenza vaccine. Front Bioeng Biotechnol 3:197
Menary J, Hobbs M, Mesquita de Albuquerque S, Pacho A, Drake PM, Prendiville A, Fuller SS (2020) Shotguns vs lasers: identifying barriers and facilitators to scaling-up plant molecular farming for high-value health products. PLoS ONE 15(3):e0229952
Meyers A, Chakauya E, Shephard E, Tanzer FL, Maclean J, Lynch A, Rybicki EP (2008) Expression of HIV-1 antigens in plants as potential subunit vaccines. BMC Biotechnol 8(1):1–15
Mini P, Demurtas OC, Valentini S, Pallara P, Aprea G, Ferrante P, Giuliano G (2018) Agrobacterium-mediated and electroporation-mediated transformation of chlamydomonas reinhardtii: a comparative study. BMC Biotechnol 18:1–12
Mir-Artigues P, Twyman RM, Alvarez D, Cerda Bennasser P, Balcells M, Christou P, Capell T (2019) A simplified techno‐economic model for the molecular pharming of antibodies. Biotechnol Bioeng 116(10):2526–2539
Moyle PM (2015) Progress in Vaccine Development: Vaccines. Current protocols in microbiology, 36(1), 18.11. 11-18.11. 26
Murad S, Fuller S, Menary J, Moore C, Pinneh E, Szeto T, Phoolcharoen W (2020) Molecular pharming for low and middle income countries. Curr Opin Biotechnol 61:53–59
Pantazica AM, van Eerde A, Dobrica MO, Caras I, Ionescu I, Costache A, Heldal I (2023) The humanized N-glycosylation pathway in CRISPR/Cas9‐edited Nicotiana benthamiana significantly enhances the immunogenicity of a S/preS1 hepatitis B virus antigen and the virus‐neutralizing antibody response in vaccinated mice. Plant Biotechnol J 21(6):1176–1190
Paolino KM, Regules JA, Moon JE, Ruck RC, Bennett JW, Remich SA, Fornillos GA (2022) Safety and immunogenicity of a plant-derived Recombinant protective antigen (rPA)-based vaccine against Bacillus anthracis: A phase 1 dose-escalation study in healthy adults. Vaccine 40(12):1864–1871
Parvathy ST (2020) Engineering plants as platforms for production of vaccines. Am J Plant Sci 11(5):707–735
Pepponi I, Diogo GR, Stylianou E, van Dolleweerd CJ, Drake PM, Paul MJ, Reljic R (2014) Plant-derived Recombinant immune complexes as self‐adjuvanting TB immunogens for mucosal boosting of BCG. Plant Biotechnol J 12(7):840–850
Pêra FF, Mutepfa DL, Khan AM, Els JH, Mbewana S, van Dijk AA, Hitzeroth II (2015) Engineering and expression of a human rotavirus candidate vaccine in Nicotiana benthamiana. Virol J 12(1):1–11
Peyret H, Brown JK, Lomonossoff GP (2019) Improving plant transient expression through the rational design of synthetic 5′ and 3′ untranslated regions. Plant Methods 15:1–13
Rybicki EP, Chikwamba R, Koch M, Rhodes JI, Groenewald J-H (2012) Plant-made therapeutics: an emerging platform in South Africa. Biotechnol Adv 30(2):449–459
Sainsbury F, Thuenemann EC, Lomonossoff GP (2009) pEAQ: versatile expression vectors for easy and quick transient expression of heterologous proteins in plants. Plant Biotechnol J 7(7):682–693
Shanmugaraj B, Rattanapisit K, Manopwisedjaroen S, Thitithanyanont A, Phoolcharoen W (2020) Monoclonal antibodies B38 and H4 produced in Nicotiana benthamiana neutralize SARS-CoV-2 in vitro. Front Plant Sci 11:589995
Singh AA, Pillay P, Naicker P, Alexandre K, Malatji K, Mach L, Tsekoa TL (2022) Transient proteolysis reduction of Nicotiana benthamiana-produced CAP256 broadly neutralizing antibodies using CRISPR/Cas9. Front Plant Sci 13:953654
Stander J, Mbewana S, Meyers AE (2022) Plant-derived human vaccines: recent developments. BioDrugs 36(5):573–589
Stoger E, Fischer R, Moloney M, Ma JK-C (2014) Plant molecular pharming for the treatment of chronic and infectious diseases. Annu Rev Plant Biol 65:743–768
Streatfield SJ (2007) Approaches to achieve high-level heterologous protein production in plants. Plant Biotechnol J 5(1):2–15
Tekoah Y, Shulman A, Kizhner T, Ruderfer I, Fux L, Nataf Y, Hanania U (2015) Large-scale production of pharmaceutical proteins in plant cell culture—the protalix experience. Plant Biotechnol J 13(8):1199–1208
Thuenemann EC, Meyers AE, Verwey J, Rybicki EP, Lomonossoff GP (2013) A method for rapid production of heteromultimeric protein complexes in plants: assembly of protective bluetongue virus-like particles. Plant Biotechnol J 11(7):839–846
Tregoning JS (2020) First human efficacy study of a plant-derived influenza vaccine. Lancet 396(10261):1464–1465. https://doi.org/10.1016/S0140-6736(20)32010-9
Tsatsakis AM, Nawaz MA, Tutelyan VA, Golokhvast KS, Kalantzi O-I, Chung DH, Yang SH (2017) Impact on environment, ecosystem, diversity and health from culturing and using GMOs as feed and food. Food Chem Toxicol 107:108–121
Tschofen M, Knopp D, Hood E, Stöger E (2016) Plant molecular farming: much more than medicines
Tsekoa TL, Lotter-Stark T, Buthelezi S, Chakauya E, Stoychev SH, Sabeta C, Morton J (2016) Efficient in vitro and in vivo activity of glyco-engineered plant-produced rabies monoclonal antibodies E559 and 62-71-3. PLoS ONE 11(7):e0159313
Tsekoa TL, Singh AA, Buthelezi SG (2020) Molecular farming for therapies and vaccines in Africa. Curr Opin Biotechnol 61:89–95
Tusé D, Nandi S, McDonald KA, Buyel JF (2020) The emergency response capacity of plant-based biopharmaceutical manufacturing-what it is and what it could be. Front Plant Sci 11:594019
Venkataraman S, Apka P, Shoeb E, Badar U, Hefferon K (2021) Plant virus nanoparticles for anti-cancer therapy. Front Bioeng Biotechnol 9:642794
Vermij P, Waltz E (2006) USDA approves the first plant-based vaccine. Nat Biotechnol 24(3):234
Watts A, Sankaranarayanan S, Watts A, Raipuria RK (2021) Optimizing protein expression in heterologous system: strategies and tools. Meta Gene 29:100899
Webster GR, Teh AYH, Ma JKC (2017) Synthetic gene design—The rationale for codon optimization and implications for molecular pharming in plants. Biotechnol Bioeng 114(3):492–502
Wilbers RH, Westerhof LB, Van Noort K, Obieglo K, Driessen NN, Everts B, Smant G (2017) Production and glyco-engineering of Immunomodulatory helminth glycoproteins in plants. Sci Rep 7(1):45910
Wu Y-Z, Li J-T, Mou Z-R, Fei L, Ni B, Geng M, Tang Y (2003) Oral immunization with rotavirus VP7 expressed in Transgenic potatoes induced high titers of mucosal neutralizing IgA. Virology 313(2):337–342
Zaboikin M, Zaboikina T, Freter C, Srinivasakumar N (2017) Non-homologous end joining and homology directed DNA repair frequency of double-stranded breaks introduced by genome editing reagents. PLoS ONE 12(1):e0169931. https://doi.org/10.1371/journal.pone.0169931
Zanganeh S, Doroudian M, Nowzari ZR, Nasirmoghadas P, Nahand JS, Sepehrpour S, Moghoofei M (2023) Viral Nanoparticles-Mediated delivery of therapeutic cargo. Adv Ther 6(10):2300082
Zhang T, Tang C (2000) Commercial production of Transgenic Bt insect-resistant cotton varieties and the resistance management for bollworm (Helicoverpa armigera Hubner). Chin Sci Bull 45:1249–1257
Zhang Y, Li D, Jin X, Huang Z (2014) Fighting Ebola with zmapp: spotlight on plant-made antibody. Sci China Life Sci 57(10):987
Author Information
National Agricultural Research Laboratories-Kawanda, National Agricultural Research Organisation, Kampala, Uganda